PFM Health Sciences Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$420M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$179M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$158M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$131M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$206M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
+$182M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$158M |
| 4 |
Travel + Leisure Co
TNL
|
+$136M |
| 5 |
Gilead Sciences
GILD
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.4% |
| 2 | Communication Services | 13.6% |
| 3 | Energy | 5.28% |
| 4 | Financials | 5.09% |
| 5 | Technology | 4.96% |
Similar funds
PFM Health Sciences's Q1 2014 Portfolio in Review
As of Q1 2014, PFM Health Sciences held 98 positions worth $5.52B, up 11% from $4.97B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
PFM Health Sciences deployed $271M of net new capital in Q1 2014, opening 38 new positions and adding to 17 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 10,702,700 shares worth $439M.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 40% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was MEDIVATION, INC., an estimated $182M trimmed.
- PFM Health Sciences's largest Q1 2014 buy was iShares MSCI Emerging Markets ETF: 10,702,700 shares worth $439M.
- PFM Health Sciences added most to Bausch Health in Q1 2014, an estimated $102M increase.
- PFM Health Sciences's biggest Q1 2014 reduction was MEDIVATION, INC., cutting an estimated $182M.
- PFM Health Sciences fully exited Amazon in Q1 2014, selling an estimated $206M.
- PFM Health Sciences's ten largest holdings make up 45% of its $5.52B portfolio in Q1 2014.
- PFM Health Sciences opened 38 new positions and closed 26 in Q1 2014.
- PFM Health Sciences's portfolio value rose 11% quarter-over-quarter to $5.52B.
Based on PFM Health Sciences's 13F filing for Q1 2014, filed 15 May 2014.